Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.

Inclusion Criteria:

• Age 18-100 years
• Histologically confirmed (according to the World Health Organization (WHO)/EORTC classification) MF/SS stages I-IV
• WHO performance status 0 -3
• Absence of psychiatric illness or condition which could interfere with the subjects' ability to understand the requirements of the study.
• Written informed consent according to International Conference on Harmonization (ICH)/(Good Clinical Practice (GCP), and Swedish regulations
• No minimum or maximum required routine laboratory data

Exclusion Criteria:

Not applicable. No exclusion criteria are specified.